Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 4 Double Blinded Study With Two Different Interventions, Each With Two Arms, to Evaluate the Clinical Efficacy of Antibiotics and the Role of Microbiology, Immunology and Genetics in Children Aged 9-36 Months With Chronic Wet Cough.

NCT06020716 is registered in ClinicalTrials.gov with Helse Stavanger HF as lead sponsor.

NCT NCT06020716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06020716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 4 Double Blinded Study With Two Different Interventions, Each With Two Arms, to Evaluate the Clinical Efficacy of Antibiotics and the Role of Microbiology, Immunology and Genetics in Children Aged 9-36 Months With Chronic Wet Cough.
Lead sponsor
Helse Stavanger HF
Phase
Phase 4
Overall status
Recruiting
Start date
August 16, 2023
Completion date
April 30, 2028
Enrollment
350 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

protracted bacterial bronchitis